Skip to menu Skip to content Skip to footer
Professor Denise Doolan
Professor

Denise Doolan

Email: 
Phone: 
+61 7 334 62159

Overview

Background

Professor Denise Doolan is Director of Research at the Institute for Molecular Bioscience. She joined IMB in 2022 and was previously Deputy Director of the Australian Institute of Tropical Health and Medicine, and Director of the JCU Centre for Molecular Therapeutics, at James Cook University.

She is a molecular immunologist, working on the development of vaccines, diagnostics and host-directed therapeutics for infectious and chronic diseases that impact global public health, with a particular focus on malaria. Her cross-disciplinary research program spans host-pathogen immunity, antigen discovery, vaccine engineering, and biomarker discovery. A particular interest is the application of state-of-the-art genome-based technologies and human models of disease system to identify novel targets for intervention against disease or that predict risk of disease.

She is a recognized world expert in malaria immunology, vaccinology, and omic-based approaches for therapeutic and diagnostic development. She has been honoured as a Fellow of the International Society for Vaccines (2017) and a Fellow of the Australian Society of Parasitology (2019) in recognition of her leadership and contribution to health and medical science in Australia and internationally.

Professor Doolan serves on a number of Executive Boards and Advisory Boards. Most recently, she has been elected as President of the International Society for Vaccines (2021-2023), and has been appointed to the Federal Government’s Australian Medical Research Advisory Board (AMRAB; 2021-2026) to provide specialist insights into Australia’s medical research and innovation priorities.

Availability

Professor Denise Doolan is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Science, The University of Queensland
  • B Sc Hons (Biochemistry), The University of Queensland
  • M Phil (Life Sciences), Griffith University
  • PhD (Molecular Immunology), The University of Queensland

Works

Search Professor Denise Doolan’s works on UQ eSpace

218 works between 1987 and 2024

181 - 200 of 218 works

2000

Journal Article

HLA-DR-promiscuous T cell epitopes frown Plasmodium falciparum pre- erythrocytic-stage antigens restricted by multiple HLA class II alleles

Doolan, Denise L., Southwood, Scott, Chesnut, Robert, Appella, Ettore, Gomez, Eduardo, Richards, Allen, Higashimoto, Yuichiro I., Maewal, Ajesh, Sidney, John, Gramzinski, Robert A., Mason, Carl, Koech, Davy, Hoffman, Stephen L. and Sette, Alessandro (2000). HLA-DR-promiscuous T cell epitopes frown Plasmodium falciparum pre- erythrocytic-stage antigens restricted by multiple HLA class II alleles. Journal of Immunology, 165 (2), 1123-1137. doi: 10.4049/jimmunol.165.2.1123

HLA-DR-promiscuous T cell epitopes frown Plasmodium falciparum pre- erythrocytic-stage antigens restricted by multiple HLA class II alleles

2000

Journal Article

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

Le, T. P., Coonan, K. M., Hedstrom, R. C., Charoenvit, Y., Sedegah, M., Epstein, J. E., Kumar, S., Wang, R., Doolan, D. L., Maguire, J. D., Parker, S. E., Hobart, P., Norman, J. and Hoffman, S. L. (2000). Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine, 18 (18), 1893-1901. doi: 10.1016/s0264-410x(99)00407-7

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

2000

Journal Article

Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?

Hoffman, S. L. and Doolan, D. L. (2000). Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?. Developments in biologicals, 104, 121-132.

Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?

1999

Journal Article

IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model

Doolan, Denise L. and Hoffman, Stephen L. (1999). IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. Journal of Immunology, 163 (2), 884-892.

IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model

1999

Journal Article

Immune effector mechanisms in malaria

Good, Michael F. and Doolan, Denise L. (1999). Immune effector mechanisms in malaria. Current Opinion in Immunology, 11 (4), 412-419. doi: 10.1016/S0952-7915(99)80069-7

Immune effector mechanisms in malaria

1999

Journal Article

CD4+ T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein

Charoenvit, Yupin, Majam, Victoria Fallarme, Corradin, Giampietro, Sacci Jr., John B., Wang, Ruobing, Doolan, Denise L., Jones, Trevor R., Abot, Esteban, Patarroyo, Manuel E., Guzman, Fanny and Hoffman, Stephen L. (1999). CD4+ T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infection and Immunity, 67 (11), 5604-5614. doi: 10.1128/iai.67.11.5604-5614.1999

CD4+ T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein

1998

Journal Article

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

Wang, R, Doolan, D L, Le, T P, Hedstrom, R C, Coonan, K M, Charoenvit, Y, Jones, T R, Hobart, P, Margalith, M, Ng, J, Weiss, W R, Sedegah, M, de Taisne, C, Norman, J A and Hoffman, S L (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (New York, N.Y.), 282 (5388), 476-80. doi: 10.1126/science.282.5388.476

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1998

Journal Article

In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines

Hedstrom, R. C., Doolan, D. L., Wang, R., Kumar, A., Sacci Jr., J. B., Gardner, M. J., Aguiar, J. C., Charoenvit, Y., Sedegah, M., Tine, J. A., Margalith, M., Hobart, P. and Hoffman, S. L. (1998). In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. International journal of molecular medicine, 2 (1), 29-38. doi: 10.3892/ijmm.2.1.29

In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines

1998

Journal Article

Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids

Wang, Ruobing, Doolan, Denise L., Charoenvit, Yupin, Hedstrom, Richard C., Gardner, Malcolm J., Hobart, Peter, Tine, John, Sedegah, Martha, Fallarme, Victoria, Sacci Jr., John B., Kaur, Manjit, Klinman, Dennis M., Hoffman, Stephen L. and Weiss, Walter R. (1998). Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infection and Immunity, 66 (9), 4193-4202. doi: 10.1128/.66.9.4193-4202.1998

Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids

1997

Journal Article

DNA vaccination as an approach to malaria control: Current status and strategies

Doolan, D. L., Hedstrom, R. C., Gardner, M. J., Sedegah, M., Wang, H., Gramzinski, R. A., Maroatith, M., Hobart, P. and Hoffman, S. L. (1997). DNA vaccination as an approach to malaria control: Current status and strategies. Current Topics in Microbiology and Immunology, 226, 37-56.

DNA vaccination as an approach to malaria control: Current status and strategies

1997

Journal Article

The development of a multivalent DNA vaccine for malaria

Hedstrom, Richard C., Doolan, Denise L., Wang, Ruobing, Gardner, Malcolm J., Kumar, Anita, Sedegah, Martha, Gramzinski, Robert A., Sacci Jr., John B., Charoenvit, Yupin, Weiss, Walter R., Margalith, Michal, Norman, Jon A., Hobart, Peter and Hoffman, Stephen L. (1997). The development of a multivalent DNA vaccine for malaria. Springer Seminars in Immunopathology, 19 (2), 147-159. doi: 10.1007/BF00870265

The development of a multivalent DNA vaccine for malaria

1997

Journal Article

DNA vaccines for malaria: The past, the present, and the future

Doolan, Denise L., Hedstrom, Richard C., Wang, Ruobing, Sedegah, Martha, Scheller, Libia F., Hobart, Peter, Norman, Jon A. and Hoffman, Stephen L. (1997). DNA vaccines for malaria: The past, the present, and the future. Indian Journal of Medical Research, 106 (AUG.), 109-119.

DNA vaccines for malaria: The past, the present, and the future

1997

Conference Publication

Malaria DNA vaccines in Aotus monkeys

Gramzinski, Robert A., Maris, Dorina C., Doolan, Denise, Charoenvit, Yupin, Obaldia, Nicanor, Rossan, Richard, Sedegah, Martha, Wang, Ruobing, Hobart, Peter, Margalith, Michal and Hoffman, Stephen (1997). Malaria DNA vaccines in Aotus monkeys. doi: 10.1016/S0264-410X(96)00270-8

Malaria DNA vaccines in Aotus monkeys

1997

Conference Publication

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use

Hoffman, Stephen L., Doolan, Denise L., Sedegah, Martha, Aguiar, Joao C., Wang, Ruobing, Malik, Anita, Gramzinski, Robert A., Weiss, Walter R., Hobart, Peter, Norman, Jon A., Margalith, Michal and Hedstrom, Richard C. (1997). Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. doi: 10.1016/S0264-410X(96)00273-3

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use

1997

Journal Article

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

Doolan, D. L. and Hoffman, S. L. (1997). Multi-gene vaccination against malaria: A multistage, multi-immune response approach. Parasitology Today, 13 (5), 171-178. doi: 10.1016/s0169-4758(97)01040-5

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

1997

Journal Article

Toward clinical trials of DNA vaccines against malaria

Hoffman, Stephen L., Doolan, Denise L., Sedegah, Martha, Wang, Ruobing, Scheller, Libia F., Kumar, Anita, Weiss, Walter R., Le, Thong P., Klinman, Dennis M., Hobart, Peter, Norman, Jon A. and Hedstrom, Richard C. (1997). Toward clinical trials of DNA vaccines against malaria. Immunology and Cell Biology, 75 (4), 376-381. doi: 10.1038/icb.1997.59

Toward clinical trials of DNA vaccines against malaria

1997

Journal Article

Pre-erythrocytic-stage immune effector mechanisms in plasmodium spp. infections

Doolan, Denise L. and Hoffman, Stephen L. (1997). Pre-erythrocytic-stage immune effector mechanisms in plasmodium spp. infections. Philosophical Transactions of the Royal Society B: Biological Sciences, 352 (1359), 1361-1367. doi: 10.1098/rstb.1997.0121

Pre-erythrocytic-stage immune effector mechanisms in plasmodium spp. infections

1997

Journal Article

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles

Doolan, Denise L., Hoffman, Stephen L., Southwood, Scott, Wentworth, Peggy A., Sidney, John, Chesnut, Robert W., Keogh, Elissa, Appella, Ettore, Nutman, Thomas B., Lal, Altaf, Gordon, Daniel M., Oloo, Aggrey and Sette, Alessandro (1997). Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity, 7 (1), 97-112. doi: 10.1016/S1074-7613(00)80513-0

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles

1996

Journal Article

Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs

Doolan, Denise L., Wizel, Benjamin and Hoffman, Stephen L. (1996). Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs. Immunologic Research, 15 (4), 280-305. doi: 10.1007/BF02935313

Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs

1996

Journal Article

DNA vaccination against malaria

Doolan, Denise L., Sedegah, Martha, Hedstrom, Richard C., Aguiar, Joao C. and Hoffman, Stephen L. (1996). DNA vaccination against malaria. Advanced Drug Delivery Reviews, 21 (1), 49-61. doi: 10.1016/0169-409X(96)00018-X

DNA vaccination against malaria

Funding

Current funding

  • 2024 - 2026
    Effective Multiple Sclerosis diagnosis based on EBV proteome screening
    MS Research Australia Project Grant
    Open grant

Past funding

  • 2023 - 2024
    Human-informed data-driven development of next-generation T cell vaccine against malaria
    United States National Institutes of Health
    Open grant
  • 2013 - 2017
    Tropical disease - immunity, pathogenesis and vaccine development: global translation (NHMRC Program Grant administered by Griffith University)
    Griffith University
    Open grant
  • 2012 - 2014
    ResTeach Funding 2012 0.1 FTE School of Medicine/School of Chemisty and Molecular Biosciences
    UQ ResTeach
    Open grant

Supervision

Availability

Professor Denise Doolan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • UNDERSTANDING THE LINK BETWEEN EBV AND MULTIPLE SCLEROSIS

    An opportunity exists for a PhD position in molecular immunology, where cutting-edge technologies will be applied to understand the molecular basis of the link between EBV and Multiple Sclerosis. Epstein-Barr virus (EBV) is the top identified causative agent of Multiple Sclerosis, but how this occurs is not known. This project aims to apply an innovative approach using proteome-wide screening of EBV to identify the subset of EBV proteins from the complete EBV proteome that triggers MS. It will compare responses in individuals with different stages of MS and apply sophisticated computational analytics to identify specific EBV proteins that predict MS disease. This EBV signature of MS could be translated into a clinic-friendly point-of-care test. If successful, this project could revolutionize the diagnosis and management of MS, providing patients with a quicker and more accurate diagnosis and enhanced quality of life.

    Subject areas: Immunology, Molecular immunology, Systems biology, Multiple Sclerosis, Autoimmunity, EBV

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan & Dr Carla Proietti

  • MOLECULAR IMMUNOLOGY OF MALARIA

    An opportunity exists for a PhD position in the molecular immunology of malaria. The focus of this project will be to apply cutting-edge technologies to understand the molecular basis of protective immunity to malaria. It will take advantage of controlled human infection models and as well as animal models to explore the mechanisms underlying protective immunity to malaria and immune responsiveness. Using a range of interdisciplinary approaches, including immune profiling, transcriptomics, proteomics, and small molecule characterization, the project aims to define the critical cells and signalling pathways required for protective immunity against malaria. It is anticipated that this research will have broad application to a wide range of infectious and chronic diseases, with important implications for vaccination.

    Subject areas: Immunology, Molecular immunology, Systems biology, Vaccinology, Malaria

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

  • VACCINE ENGINEERING

    An opportunity exists for a PhD position in vaccine engineering. Vaccines are one of the most effective health care interventions but remain a challenge for many diseases, and in particular intracellular pathogens such as malaria where T cell responses are particularly desirable. We have been exploring novel approaches to rationally design an effective vaccine against challenging disease targets. By taking advantage of recent advances in genomic sequencing, proteomics, transcriptional profiling, and molecular immunology, we have discovered unique targets of T cell responses or antibody response. This project will test these antigens as vaccine candidates by assessing immunogenicity, protective capacity and biological function using different vaccine platforms. By designing an effective vaccine from genomic data, this project is expected to result in significance advances in vaccinology as well as immunology, with important public health outcomes.

    Subject areas: Immunology, Vaccinology, Molecular immunology, Malaria, Vaccine engineering, Vaccine design

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisor:

    Professor Denise Doolan (IMB) & Professor Carla Proietti (IMB)

  • SYSTEMS IMMUNOLOGY AND MULTI-OMICS APPROACHES TO UNDERSTAND PROTECTIVE IMMUNITY TO HUMAN MALARIA

    This PhD project aims to develop and apply computational approaches that integrate systems biology and molecular immunology to understand host-pathogen immunity and predict immune control of malaria. The project will utilise systems-based immunology and multi-omics approaches to profile the host immune response in controlled infection models of malaria at molecular, cellular, transcriptome and proteome-wide scale.

    The overall aim will be to develop and apply omics-based technologies and computational tools, including network theory and machine learning, to integrate multiple high-dimensional datasets and reveal novel insights into host-pathogen immunity and predict immune responsiveness and parasite control. Modelling of large-scale existing datasets, including those generated by single-cell RNA-sequencing technologies, may also be a feature of this project. The opportunity to identify new knowledge and integrate this with experimental data produced by our laboratory will be instrumental to extending the impact of these bioinformatics analyses. This project will provide an opportunity to be at the forefront in cutting-edge technologies and advances in computational analysis of integrated high-dimensional omic data.

    Methodologies: Bioinformatics, Machine Learning, Immunology, Systems Immunology, Systems Biology, Genomics/Proteomics/Transcriptomics, Molecular and Cell Biology, Statistics

    Eligibility: Entry: BSc Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: Experience with programming languages, mathematics, statistics and/or background in immunology and molecular sciences, with an interest in integrating the fields of immunology and bioinformatics.

    Excellent computer, communication, and organisational skills are required. Forward thinking, innovation and creativity are encouraged.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

    Associate Professor Jessica Mar (AIBN)

Supervision history

Current supervision

  • Doctor Philosophy

    Defining the molecular basis of immune heterogeneity between individuals using immunoproteomics

    Principal Advisor

  • Doctor Philosophy

    Systems immunology and multi-omics approaches to understand protective immunity to human malaria

    Principal Advisor

Completed supervision

Media

Enquiries

For media enquiries about Professor Denise Doolan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au